Efficacy and Safety Study of SPL7013 Gel to Prevent the Recurrence of Bacterial Vaginosis (BV)

Completed · Phase 3 · Has a placebo group

Conditions studied: Bacterial Vaginosis

In brief

A double-blind, phase 3 study to determine the efficacy of SPL7013 Gel when administered on alternate days for 16 weeks, compared to placebo gel in preventing the recurrence of BV in women with a history of recurrent BV.

Key facts

Study ID
NCT02236156
Run by
Starpharma Pty Ltd
People needed
637
Starts
2014-10-03
Expected to finish
2016-10-04
Last updated by the study team
2018-06-25

Who can join

Age: 18 and older, up to 45. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.